KYT Dental Services
Alendronate · Dental implants

Alendronate and dental implant healing

Quick answer

Dental implants in patients on oral alendronate generally have success rates close to non-users. The MRONJ concern is real but rare with oral bisphosphonates, especially for short and medium durations of use. The risk rises with treatment beyond four to five years and is much higher with IV bisphosphonates used in cancer treatment. Most patients on Fosamax can get implants safely with appropriate planning and post-surgical follow-up.

The mechanism
Why bisphosphonates affect implant placement

Implant success depends on osseointegration: bone growing into the surface of the titanium implant. This requires active bone remodeling, the same process bisphosphonates slow down. The intuition is that bisphosphonates would impair osseointegration, but the clinical reality is more nuanced. Multiple studies show that oral bisphosphonate users have implant survival rates similar to non-users in the short and medium term.

The bigger concern is MRONJ (medication-related osteonecrosis of the jaw). The risk is concentrated at surgical trauma sites, which includes implant placement. For most patients on oral alendronate for less than four years, the absolute risk is low (well under 1 percent in studies), but it is not zero. For patients on IV bisphosphonates used in cancer treatment, the risk is meaningfully higher and changes how dental surgery is planned.

The risk profile also depends on the implant site (posterior mandible is highest risk), the surgical technique (more invasive placement raises risk), and other factors like steroid use, smoking, and diabetes. A patient on five years of oral alendronate with no other risk factors is a different conversation than the same patient with multiple risk factors stacked.

Practical steps
What to do if you are on alendronate and considering implants
  • Tell your dentist your full medication history, especially how long you have been on alendronate.
  • Coordinate with your prescribing physician. They can confirm your underlying osteoporosis risk and discuss whether a brief drug holiday is appropriate before surgery.
  • Get a current bone density report. The implant planning is informed by your jaw bone quality, which we image directly with a cone beam CT.
  • Optimize oral hygiene before surgery. Lower oral bacterial load reduces MRONJ and infection risk.
  • Plan for slightly more conservative surgical technique. Atraumatic flap design and careful socket preservation matter more in bisphosphonate patients than in others.
  • Schedule longer follow-up. We watch implant sites carefully in the first six months in patients on bisphosphonates.
Red flags
When to call your dentist after implant surgery
  • An area of exposed bone in the mouth, even if not painful.
  • Pain that gets worse after day three instead of better.
  • Swelling or pus from the surgical site.
  • The implant feels loose or wobbly at any point.
  • A non-healing socket or surgical site weeks after the procedure.
Common questions
What patients ask about Alendronate and dental implant healing.
Can I get a dental implant on alendronate?
In most cases, yes. Patients on oral alendronate for less than four to five years generally have implant success rates close to non-users. Longer durations or other risk factors (smoking, diabetes, steroid use, IV bisphosphonate history) shift the conversation toward more caution.
Should I stop alendronate before getting an implant?
Sometimes, but never on your own. Some prescribing physicians recommend a brief drug holiday before invasive dental surgery in patients on long-term oral bisphosphonates. The decision balances the bone protection benefits of continuing alendronate against the potential MRONJ benefits of a pause. This is coordinated between your dentist and your physician.
What is the actual MRONJ risk after implant placement on Fosamax?
For patients on oral alendronate, published estimates put the risk at well under 1 percent. The risk rises with treatment duration past four to five years and is much higher in patients on IV bisphosphonates for cancer. Specific risk estimation depends on your full medical history.
Are implants in the upper jaw safer than the lower jaw on bisphosphonates?
MRONJ is more commonly reported in the posterior mandible (lower back jaw) than in the upper jaw. Implant planning takes this into account. Sometimes a different site or restoration approach is suggested in higher-risk patients.
If I get MRONJ around an implant, what happens?
Early MRONJ is usually managed conservatively with antibiotics, gentle hygiene, and topical care. Many cases resolve with this approach. More advanced cases require surgical management with an oral surgeon. The earlier it is caught, the easier it is to treat, which is why post-surgical follow-up matters in bisphosphonate patients.
Talk to a dentist about your case
Bring your medication list to your visit.

General guidance is a starting point. Your specific dental plan depends on your medical history, your other medications, and what your mouth looks like in person. Schedule a consultation and we’ll walk through it.

Schedule a consultationCall (833) 598-3368

Reviewed by Dr. Isaac Sun, DDS.

This page is general information, not medical advice. Do not start, stop, or change any medication based on what you read here. Talk to your prescribing physician and your dentist about your specific situation.